Multisectoral, Combination HIV Prevention for Adolescent Girls and Young Women: A Qualitative Study of the DREAMS Implementation Trajectory in Zambia.


Journal

Global health, science and practice
ISSN: 2169-575X
Titre abrégé: Glob Health Sci Pract
Pays: United States
ID NLM: 101624414

Informations de publication

Date de publication:
31 10 2022
Historique:
received: 04 03 2022
accepted: 13 09 2022
entrez: 31 10 2022
pubmed: 1 11 2022
medline: 3 11 2022
Statut: epublish

Résumé

To identify solutions to the implementation challenges with the DREAMS (Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe women) Partnership in Zambia, this study examines the rollout and evolution of the DREAMS Partnership's implementation. In September-October 2018, implementing partner (IP) staff (n=15) and adolescent girls and young women (AGYW) participating in DREAMS programming (n=32) completed in-depth interviews exploring early rollout and scale-up of DREAMS, experiences with program participation, and shifting service delivery approaches in response to emerging implementation challenges. Inductive and deductive thematic analysis of 47 interviews uncovered salient service delivery facilitators and barriers in the first 2 years of DREAMS implementation, which were subsequently mapped onto the following domains: reach, effectiveness, adoption, implementation, and maintenance. Key implementation successes identified by IP staff included using standardized recruitment and risk assessment tools across IP organizations, using a mentor model for delivering program content to AGYW, and offering centralized service delivery at venues accessible to AGYW. Implementation challenges identified early in the DREAMS Partnership's lifecycle were rectified through adaptive service delivery strategies. Monthly in-person coordination meetings were established to resolve IP staff jurisdictional disputes over recruitment and target setting. To address high participant attrition, IP staff adopted a cohort approach to sequentially recruit AGYW who enrolled together and provided social support to one another to sustain involvement in DREAMS programming. Prominent barriers to implementation fidelity included challenges recruiting the highest-risk AGYW (e.g., those out of school), limited resources to incentivize participation by young women, and inadequate planning to facilitate absorption of individual DREAMS interventions by the public sector upon project conclusion. Delivering multisectoral HIV prevention programs like DREAMS with fidelity requires a robust implementation infrastructure (e.g., adaptable workplans and harmonized record management systems), early coordination between IP organizations, and sustained financial commitments from donors.

Identifiants

pubmed: 36316147
pii: GHSP-D-22-00089
doi: 10.9745/GHSP-D-22-00089
pmc: PMC9622277
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIMH NIH HHS
ID : F31 MH126796
Pays : United States

Informations de copyright

© Rosen et al.

Références

Hum Resour Health. 2013 Feb 19;11:7
pubmed: 23418879
Trop Med Int Health. 2006 Jan;11(1):3-16
pubmed: 16398750
BMC Health Serv Res. 2011 Oct 12;11:266
pubmed: 21992700
PLoS One. 2018 Jul 19;13(7):e0199733
pubmed: 30024908
BMC Public Health. 2019 Oct 30;19(1):1417
pubmed: 31666043
BMC Public Health. 2016 Aug 15;16:789
pubmed: 27527339
PLoS One. 2018 Dec 7;13(12):e0208167
pubmed: 30532210
EClinicalMedicine. 2019 May 20;10:10-31
pubmed: 31193863
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
PLoS One. 2018 Jun 20;13(6):e0198898
pubmed: 29924827
BMC Public Health. 2021 Apr 27;21(1):806
pubmed: 33906614
J Int AIDS Soc. 2019 Dec;22(12):e25410
pubmed: 31793748
PLoS One. 2018 Sep 13;13(9):e0203929
pubmed: 30212561
AIDS Behav. 2017 Sep;21(9):2746-2759
pubmed: 27631367
Lancet Glob Health. 2013 Dec;1(6):e362-70
pubmed: 25104601
J Int AIDS Soc. 2020 Sep;23 Suppl 5:e25575
pubmed: 32869481
Lancet. 2012 Apr 7;379(9823):1320-9
pubmed: 22341825
PLoS One. 2018 Mar 15;13(3):e0194301
pubmed: 29543858
Lancet Glob Health. 2016 Dec;4(12):e978-e988
pubmed: 27815148
Int J Public Health. 2020 May;65(4):399-411
pubmed: 32270233
PLoS One. 2018 Sep 14;13(9):e0203208
pubmed: 30216356
PLoS One. 2018 Dec 13;13(12):e0208243
pubmed: 30543640
BMJ Open. 2022 Feb 1;12(2):e047843
pubmed: 35105561
AIDS. 2022 Jun 15;36(Suppl 1):S39-S49
pubmed: 35766574
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
Trop Med Infect Dis. 2021 Jul 15;6(3):
pubmed: 34287365
Am J Prev Med. 2012 Sep;43(3):337-50
pubmed: 22898128
JAMA Netw Open. 2022 Apr 1;5(4):e228640
pubmed: 35452103
BMJ. 2008 Aug 07;337:a506
pubmed: 18687720
Hum Resour Health. 2019 Dec 17;17(1):101
pubmed: 31847909
PLoS Med. 2021 Oct 25;18(10):e1003837
pubmed: 34695112
BMC Public Health. 2019 Jul 8;19(1):897
pubmed: 31286914
BMJ. 2013 Nov 20;347:f6753
pubmed: 24259324
AIDS. 2014 Jul;28 Suppl 3:S389-97
pubmed: 24991912
PLoS One. 2018 Sep 28;13(9):e0198783
pubmed: 30265667
AIDS. 2022 Jun 15;36(Suppl 1):S5-S14
pubmed: 35766571
J Int AIDS Soc. 2014 Feb 13;17:18845
pubmed: 24560342
PLoS One. 2018 Dec 26;13(12):e0208689
pubmed: 30586376
J Acquir Immune Defic Syndr. 2016 May 1;72(1):96-104
pubmed: 26825176
AIDS. 2017 Sep 24;31(15):2127-2134
pubmed: 28692544

Auteurs

Joseph G Rosen (JG)

Population Council, Lusaka, Zambia. jrosen72@jhu.edu.
Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Maurice Musheke (M)

Population Council, Lusaka, Zambia.

Drosin Mulenga (D)

Population Council, Lusaka, Zambia.

Edith S Namukonda (ES)

Population Council, Lusaka, Zambia.

Nrupa Jani (N)

Social and Behavioral Research, Population Council, Washington, DC, USA.

Michael T Mbizvo (MT)

Population Council, Lusaka, Zambia.

Julie Pulerwitz (J)

Social and Behavioral Research, Population Council, Washington, DC, USA.

Sanyukta Mathur (S)

Social and Behavioral Research, Population Council, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH